Can education and support ease the burden of pulmonary hypertension?
NCT ID NCT07429552
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a dynamic blended learning module for 49 people with pulmonary hypertension, a chronic disease causing symptoms like shortness of breath and fatigue. The program included face-to-face education, regular phone follow-ups, and a video from a patient who successfully managed their symptoms. Researchers compared symptom management and quality of life between those who received the program and those who got standard care over nine months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dynamic Blended Education Module (DBEM) including individualized education, telephone follow-up, and an educational video
- What this could lead to
- If successful, this approach could provide a structured way for pulmonary hypertension patients to better manage daily symptoms and improve quality of life.
- What could go wrong
- This is a small, completed study with only 49 participants, so results may not apply to all patients. The intervention is educational, not a medical treatment, so it cannot cure the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
49 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of pulmonary hypertension. * Functional class I-IV. * Confirmed diagnosis of pulmonary hypertension for at least 6 months. * Native Turkish speaker. * Age ≥18 years * Voluntary willingness to participate in the study Exclusion Criteria: * Individuals with cognitive impairments or communication difficulties that would interfere with study participation * Patients who have previously undergone pulmonary endarterectomy and currently exhibit normal pulmonary artery pressures * Individuals who decline to provide informed consent for participation * Patients with an unstable or acute clinical condition
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Learning are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Provincial Directorate of Health
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a standard 40 mm needle reach the hip muscle in people with higher BMI?
- Five simple signs could help nurses score surgical pain in turkish
- Can daily mindful breathing ease heart failure symptoms?
- 150,000 children to be tracked from birth to old age in massive health study
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care
- Inhaled xenon gas could reveal hidden lung vessel disease without catheter